FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称NAMODENOSON
异名/同义词.BETA.-D-RIBOFURANURONAMIDE, 1-(2-CHLORO-6-(((3-IODOPHENYL)METHYL)AMINO)-9H-PURIN-9-YL)-1-DEOXY-N-METHYL-
1-(2-CHLORO-6-(((3-IODOPHENYL)METHYL)AMINO)-9H-PURIN-9-YL)-1-DEOXY-N-METHYL-.BETA.-D-RIBOFURANURONAMIDE
2-CHLORO-N(6)-(3-IODOBENZYL)ADENOSINE-5'-N-METHYLURONAMIDE
2-CHLORO-N6-(3-IODOBENZYL)ADENOSINE-5'-N-METHYLURONAMIDE
CF102
CF-102
CHLORO-IB-MECA
CL-IB-MECA
NAMODENOSON
NAMODENOSON [INN]
NAMODENOSON [USAN]
NAMODENOSON [WHO-DD]
CAS登记号163042-96-4
物质唯一标识(Unique Ingredient Identifier)Z07JR07J6C
分子式C18H18ClIN6O4
国际化合物标识(International Chemical Identifier,InChI)IPSYPUKKXMNCNQ-PFHKOEEOSA-N
SMILESn1(c2nc(nc(NCc3cc(ccc3)I)c2nc1)Cl)[C@H]4[C@@H]([C@@H]([C@H](O4)C(NC)=O)O)O
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System